| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 101.2k | $2.05 | $207.4k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 54.6k | $13.50 | $737.1k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 27.3k | $5.09 | $139k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 95.9k | $2.62 | $251.3k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 150.8k | $15.00 | $2.3M | | 05/31/2022 |
| 01/27/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 101.2k | $2.05 | $207.4k | | 01/27/2022 |
| 08/04/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 27.3k | $5.09 | $139k | | 08/04/2021 |
| 03/04/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 54.6k | $13.50 | $737.1k | | 03/04/2021 |
| 08/06/2020 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 150.8k | $15.00 | $2.3M | | 08/06/2020 |
| 02/28/2019 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 50.2k | $8.36 | $419.7k | | 02/28/2019 |
| 02/20/2018 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 45k | $6.31 | $284k | | 02/20/2018 |
| 08/22/2017 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 10k | $3.10 | $31k | | 08/22/2017 |
| 08/22/2017 | Aeglea BioTherapeutics, Inc. | AGLE | Grant | Employee Stock Option (right to buy) | 165k | $3.10 | $511.5k | | 08/22/2017 |